title: The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty.
abstract: The degree of anticoagulation and its effect on the frequency of abrupt coronary artery closure, coronary ischemia, bleeding complications requiring transfusion, and death were examined in 336 patients after elective percutaneous transluminal coronary angioplasty (PTCA). All patients received a bolus of 10,000 U of heparin at the beginning of the procedure followed by a continuous infusion of 2000 U/hr. At the conclusion of the procedure the infusion was reduced to 1000 U/hr and continued for 18 to 24 hours at which time the heparin infusion was suspended to allow removal of arterial and venous access sheaths. Partial thromboplastin time (PTT) was examined while patients continued to receive the heparin infusion. There was a variable degree of PTT prolongation in response to a standard dose of heparin with a range of 34 seconds to "greater than 150 seconds." Patients were divided into two groups according to the degree of heparin-induced PTT prolongation: group A included 271 patients with PTT greater than or equal to 3 times the control value, and group B comprised 65 patients with PTT less than 3 times the control value. Ischemic complications were analyzed on day 1 after PTCA and at hospital discharge. Bleeding complications and mortality were examined only at hospital discharge. There was a significant reduction in the incidence of abrupt coronary artery closure in group A on day 1 (1.5% vs 10.7%, p less than 0.001) and at hospital discharge (2.6% vs 10.7%, p less than 0.003).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Medicine, Graduate Hospital, Philadelphia, Pa.
authors.forename: T F
authors.initials: TF
authors.lastname: McGarry
authors.forename: R S
authors.initials: RS
authors.lastname: Gottlieb
authors.forename: J
authors.initials: J
authors.lastname: Morganroth
authors.forename: S L
authors.initials: SL
authors.lastname: Zelenkofske
authors.forename: H
authors.initials: H
authors.lastname: Kasparian
authors.forename: P R
authors.initials: PR
authors.lastname: Duca
authors.forename: R M
authors.initials: RM
authors.lastname: Lester
authors.forename: T H
authors.initials: TH
authors.lastname: Kreulen
mesh_terms: D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D003327:Coronary Disease / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012008:Recurrence; D012189:Retrospective Studies; D012727:Sex Characteristics
chemical_list: D000925:Anticoagulants; D006493:Heparin